Metformin for the management of tuberous sclerosis: What does the evidence tell us?

Detalles Bibliográficos
Autores principales: Srinivasan, Anirudh, Naga Shashi Kiran, Beti, Koduvath, Abdulla, Pal, Auroprakash, Suresh, Ananthu, Kannan, Amudhan, Ravichandran, Mirunalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600156/
https://www.ncbi.nlm.nih.gov/pubmed/34803555
http://dx.doi.org/10.17179/excli2021-4213
_version_ 1784601091509321728
author Srinivasan, Anirudh
Naga Shashi Kiran, Beti
Koduvath, Abdulla
Pal, Auroprakash
Suresh, Ananthu
Kannan, Amudhan
Ravichandran, Mirunalini
author_facet Srinivasan, Anirudh
Naga Shashi Kiran, Beti
Koduvath, Abdulla
Pal, Auroprakash
Suresh, Ananthu
Kannan, Amudhan
Ravichandran, Mirunalini
author_sort Srinivasan, Anirudh
collection PubMed
description
format Online
Article
Text
id pubmed-8600156
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Leibniz Research Centre for Working Environment and Human Factors
record_format MEDLINE/PubMed
spelling pubmed-86001562021-11-19 Metformin for the management of tuberous sclerosis: What does the evidence tell us? Srinivasan, Anirudh Naga Shashi Kiran, Beti Koduvath, Abdulla Pal, Auroprakash Suresh, Ananthu Kannan, Amudhan Ravichandran, Mirunalini EXCLI J Letter to the Editor Leibniz Research Centre for Working Environment and Human Factors 2021-09-27 /pmc/articles/PMC8600156/ /pubmed/34803555 http://dx.doi.org/10.17179/excli2021-4213 Text en Copyright © 2021 Srinivasan et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ) You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Letter to the Editor
Srinivasan, Anirudh
Naga Shashi Kiran, Beti
Koduvath, Abdulla
Pal, Auroprakash
Suresh, Ananthu
Kannan, Amudhan
Ravichandran, Mirunalini
Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title_full Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title_fullStr Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title_full_unstemmed Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title_short Metformin for the management of tuberous sclerosis: What does the evidence tell us?
title_sort metformin for the management of tuberous sclerosis: what does the evidence tell us?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600156/
https://www.ncbi.nlm.nih.gov/pubmed/34803555
http://dx.doi.org/10.17179/excli2021-4213
work_keys_str_mv AT srinivasananirudh metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT nagashashikiranbeti metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT koduvathabdulla metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT palauroprakash metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT sureshananthu metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT kannanamudhan metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus
AT ravichandranmirunalini metforminforthemanagementoftuberoussclerosiswhatdoestheevidencetellus

Ejemplares similares